NCT00435838已完成不适用
A Retrospective, Multi-Centre Observational Study to Evaluate Disease Management and Adverse Events in Adult Subjects With HIV-1 Infection Who Were Withdrawn From CNA106030 Due to a Positive HLA-B*5701 Test Result
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 35
- 试验地点
- 1
研究概览
简要总结
This is a retrospective observational study which follows on from CNA106030 (a study evaluating whether prospective genetic screening for HLA-B*5701 can reduce the incidence of hypersensitivity reactions to abacavir). This study aims to collect data on approximately 35 subjects who withdrew from CNA106030 when found to be HLA-B*5701 positive. HIV disease management and adverse event data in these subjects, where the risk/benefit ratio of treatment with abacavir may alter subsequent prescribing, will be collected
研究设计
- 研究类型
- Observational
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects who have received notification not to receive abacavir in the CNA106030 study because of a positive HLA-B*5701 screen result, and were subsequently withdrawn from protocol CNA
- •Subjects willing and able to understand and provide written informed consent prior to participation in this study.
- •French subjects: In France, a subject will be eligible for inclusion in this study only if either affiliated to or a beneficiary of a social security category.
- •Exclusion criteria:
- •Subjects who were not enrolled in the CNA106030 study
- •Subjects who are not HLA-B*5701 positive
- •Subjects who do not consent to being told their HLA-B*5701 status
排除标准
- 未提供
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Clinical and Demographic Features of Patients With Moderate to Severe Active Systemic Lupus Erythematosus in RussiaSystemic Lupus ErythematosusNCT06759519AstraZeneca637
已完成
不适用
Ribociclib in Combination With Non-steroidal Aromatase Inhibitors in Patients With Advanced Breast CancerBreast CancerNCT05569187Novartis Pharmaceuticals76
已完成
不适用
A Multi-center Retrospective Study With Secondary Use of Data of Tafinlar (Dabrafenib) Plus Mekinist (Trametinib) in Chinese Patients With BRAF V600 Mutation Positive MelanomaBRAF V600 Mutation Positive MelanomaNCT06337617Novartis Pharmaceuticals90
已完成
不适用
Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC)Prostatic NeoplasmsNCT02443571Blue Earth Diagnostics714
已完成
不适用
Retrospective Cohort Observational Study to Evaluate the Effectiveness and Safety of Fresh or Frozen Embryo TransferInfertility, FemaleNCT05130125LG Chem1,166